1,045
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Phylogenetic analysis reveals two genotypes of the emerging fungus Mucor indicus, an opportunistic human pathogen in immunocompromised patients

, , &
Pages 1-7 | Received 26 Jan 2017, Accepted 22 May 2017, Published online: 15 Jan 2019

References

  • Roden MM, Zaoutis TE, Buchanan WLet al.Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41: 634–653.
  • Prabhu RM, Patel R.Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10 (Suppl 1): 31–47.
  • Ribes JA, Vanover-Sams CL, Baker DJ.Zygomycetes in human disease. Clin Microbiol Rev 2000;13: 236–301.
  • Almyroudis NG, Sutton DA, Linden Pet al.Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006;6: 2365–2374.
  • Hamdi T, Karthikeyan V, Alangaden GJ.Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature. Int J Nephrol 2014;2014: 950643.
  • Page AV, Evans AJ, Snell Let al.Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008;10: 419–425.
  • Ville S, Talarmin JP, Gaultier-Lintia Aet al.Disseminated mucormycosis with cerebral involvement owing to Rhizopus microsporus in a kidney recipient treated with combined liposomal amphotericin B and posaconazole therapy. Exp Clin Transplant 2016;14: 96–99.
  • Koteda S, Nomura K, Hashiguchi Met al.[Fatal zygomycosis caused by Mucor indicus after haplo-identical stem cell transplantation]. Rinsho Ketsueki 2013;54: 311–315.
  • Greenberg RN, Mullane K, van Burik JAet al.Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50: 126–133.
  • Karthaus M, Cornely OA.Second-line treatment in invasive mould infections. Mycoses 2006;49 (Suppl 1): 23–26.
  • Taj-Aldeen SJ, Gene J, Al Bozom Iet al.Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum. Med Mycol 2006;44: 547–552.
  • de Hoog GS, Guarro J, Gene J et al. (eds). Atlas of Clinical Fungi. 2nd ed. CBS, Utrecht, The Netherlands, and Univesitat Rovira i Virgili, Reus, Spain, 2000, p88.
  • Bolano A, Stinchi S, Preziosi Ret al.Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res 2001;1: 221–224.
  • Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo Aet al.Reclassification of the Candidahaemulonii complex as Candida haemuloniiC. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol 2012;50: 3641–3651.
  • Altschul SF, Gish W, Miller Wet al.Basic local alignment search tool. J Mol Biol 1990;215: 403–410.
  • Tamura K, Stecher G, Peterson Det al.MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013;30: 2725–2729.
  • Hasegawa M, Kishino H, Yano T.Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985;22: 160–174.
  • Seaby D.Differentiation of Trichoderma taxa associated with mushroom production. Plant Pathology 1996;45: 905–912.
  • Kontoyiannis DP, Lionakis MS, Lewis REet al.Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005;191: 1350–1360.
  • Nucci M, Marr KA.Emerging fungal diseases. Clin Infect Dis 2005;41: 521–526.
  • Krasinski K, Holzman RS, Hanna Bet al.Nosocomial fungal infection during hospital renovation. Infecti Control 1985;6: 278–282.
  • ter Borg F, Kuijper EJ, van der Lelie H.Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scand J Infect Dis 1990;22: 499–501.
  • Repentigny L, St-Germain G, Charest Het al.Fatal zygomycosis caused by Mucor indicus in a child with an implantable left ventricular assist device. Pediatr Infect Dis J 2008;27: 365–369.
  • Skiada A, Pagano L, Groll Aet al.Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011;17: 1859–1867.
  • Singh N, Aguado JM, Bonatti Het al.Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 2009;200: 1002–1011.
  • Neofytos D, Treadway S, Ostrander Det al.Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis 2013;15: 233–242.
  • Husain S, Silveira FP, Azie Net al.Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance(R) registry analysis. Med Mycol 2016;55: 269–277.
  • Jeong SJ, Lee JU, Song YGet al.Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis. Mycoses 2015;58: 746–752.
  • Sun HY, Aguado JM, Bonatti Het al.Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant 2009;9: 2166–2171.
  • Cornely OA, Arikan-Akdagli S, Dannaoui Eet al.ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014;20 (Suppl 3): 5–26.
  • Sun HY, Singh N.Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis 2011;11: 301–311.
  • Arendrup MC, Jensen RH, Meletiadis J.In vitro activity of isavuconazole and comparators against clinical isolates of the Mucorales order. Antimicrob Agents Chemother 2015;59: 7735–7742.
  • Chowdhary A, Kathuria S, Singh PKet al.Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses 2014;57 (Suppl 3): 97–107.
  • Douvin D, Lefichoux Y, Huguet C.[Gastric phycomycosis. Early anatomo-pathological and mycological diagnosis. Favorable course under medical then surgical treatment]. Arch Anat Pathol 1975;23: 133–138.
  • Oliver MR, Van Voorhis WC, Boeckh Met al.Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis 1996;22: 521–524.
  • Mata-Essayag S, Magaldi S, de Capriles CHet al.Mucor indicus necrotizing fasciitis. Int J Dermatol 2001;40: 406–408.
  • Sobel JD.Vaginal mucormycosis: a case report. Infect Dis Obstet Gynecol 2001;9: 117–118.
  • Aboltins CA, Pratt WA, Solano TR.Fungemia secondary to gastrointestinal Mucor indicus infection. Clin Infect Dis 2006;42: 154–155.
  • Deja M, Wolf S, Weber-Carstens Set al.Gastrointestinal zygomycosis caused by Mucor indicus in a patient with acute traumatic brain injury. Med Mycol 2006;44: 683–687.
  • McDermott NE, Barrett J, Hipp Jet al.Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109: e64–e69.
  • Luo Y, Zeng F, Huang Xet al.Successful treatment of a necrotizing fasciitis patient caused by Mucor indicus with amphotericin B and skin grafting. Mycopathologia 2014;177: 187–192.